Genetic testing is coming to a cruise ship! The New York Post reported that the MV Narrative will be launched this year by Storylines. CruiseCritic describes this vessel as “a residential ship that will create a floating ‘neighborhood’ for a community of up to 1,000 people, including families … With 547 ‘residences,’ owners buy into […]
March 10, 2025, Intelligence: Late-Breaking Lab News
- By Robert Michel
- > From the Volume XXXII, No. 4 - March 10, 2025 Issue
- Tags: Abbott Diagnostics, Abbott Laboratories, Cerner, CompuGroup, Cruise Critic, Definitive Healthcare, Diana Voorhees, DV & Associates, GHX, Hamamatsu, HC1, Holy Cross Hospitals, LAB-Interlink, labotix, Matt Martocci, McKesson, Millennium Health, MV Narrative, NASDAQ, New York Post, Novartis, Ohio State University, Peter Manes, QuidelOrtho, Salesforce, Sectra, Siemens Medical Solutions, Storylines, T2 Biosystems, TLA, Tom Zarzycki, total laboratory automation, University of Utah
